Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

CNS 4

Conditions

Glioma 4Astrocytoma 3Brain Neoplasms 2Oligodendroglioma 1Lymphoma, Follicular 1Healthy Adult Participants 1

Interventions

Temozolomide 42Magnetic Resonance Spectroscopy 41Radiotherapy 22Specimen Handling 18Biopsy 13X-Rays 10Radiation 10trametinib 8Bevacizumab 8Nivolumab 7Blood Specimen Collection 7olaparib 6fluorodopa F 18 6dabrafenib 6Radiotherapy, Intensity-Modulated 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 6Lomustine 6pembrolizumab 5abemaciclib 5Standard of Care 5vorasidenib 4ulixertinib 4larotrectinib 4ivosidenib 4erdafitinib 4Surgical Procedures, Operative 4Dianhydrogalactitol 4Cyclophosphamide 4Aminolevulinic Acid 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Glioma × vorasidenib × 1 year × Clear all
NCT07629089 2026-06-05

VALIENT

University of Pittsburgh

Phase 1 Not yet recruiting
24 enrolled
CNS

Brain Neoplasms, Glioma

NCT07547163 2026-04-23

LGG PRO's

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Recruiting
90 enrolled
CNS

Glioma

NCT07240662 2026-01-09

VIOLETA

iOMEDICO AG

Recruiting
150 enrolled
CNS

Glioma

NCT05609994 2025-07-18

ViCToRy

Duke University

Phase 1 Recruiting
48 enrolled
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡